Home › Trigemina Presents Data On Intranasal Oxytocin For The Treatment Of Trigeminal Neuralgia
 

Keywords :   


Trigemina Presents Data On Intranasal Oxytocin For The Treatment Of Trigeminal Neuralgia

2013-09-04 06:35:32| drugdiscoveryonline News Articles

Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, announced that David C. Yeomans, Ph.D., Chief Scientist and Founder of Trigemina, as well as the Director of Pain Research at Stanford University School of Medicine, presented at the 2013 Napa Pain Conference on August 23rd – 25th, 2013 in Napa, California

Tags: data treatment presents intranasal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Subtropical Storm Patty Forecast Discussion Number 1
02.11Subtropical Storm Patty Wind Speed Probabilities Number 1
02.11Subtropical Storm Patty Forecast Advisory Number 1
02.11Subtropical Storm Patty Public Advisory Number 1
02.11Summary for Subtropical Storm Patty (AT2/AL172024)
02.11Tropical Storm Lane Graphics
02.11Tropical Storm Lane Forecast Discussion Number 3
More »